Mark Jeffrey DeLong, Senior Vice President at Apellis Pharmaceuticals, Inc. (APLS), sold 10,000 shares at $59.50 ($608K) on 2022-08-04, disclosed to the SEC on 2022-08-08.
Open-market sale of $608k APLS by Senior Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.50 | 5,000 | $298K | 49.0% |
| 2 | $62.00 | 5,000 | $310K | 51.0% |
| Total | $60.75 avg | 10,000 | $608K | 100% |
| Filing → |
| APLS | SELL | 2026-01-21 | $26K | — | Filing → |
| APLS | SELL | 2026-01-15 | $39K | — | Filing → |
| APLS | SELL | 2025-02-12 | $10K | — | Filing → |